Related references
Note: Only part of the references are listed.Evolving phenotypes to endotypes: is precision medicine achievable in asthma?
Diego Bagnasco et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2020)
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study
Dirkje S. Postma et al.
LANCET RESPIRATORY MEDICINE (2019)
Biomarkers and asthma management: analysis and potential applications
Levi B. Richards et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Periostin: The bone and beyond
L. Idolazzi et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2017)
Asthma Control and Sputum Eosinophils: A Longitudinal Study in Daily Practice
Sophie F. Demarche et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)
Serum periostin during omalizumab therapy in asthma A tool for patient selection and treatment evaluation
Marco Caminati et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2017)
Prevalence and reversibility of lung hyperinflation in adult asthmatics with poorly controlled disease or significant dyspnea
T. Perez et al.
ALLERGY (2016)
Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma
T. Tajiri et al.
ALLERGY (2016)
Roles of Periostin in Respiratory Disorders
Kenji Izuhara et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma Effects Across a Broad Range of Eosinophil Counts
Jonathan Corren et al.
CHEST (2016)
Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels A Randomized Phase 3 Study
Leif Bjermer et al.
CHEST (2016)
Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement
Luis Puente-Maestu et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Eugene R. Bleecker et al.
LANCET (2016)
Benralizumab, an anti-interleukin-5 receptor a monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
J. Mark FitzGerald et al.
LANCET (2016)
The prevalence of small airways disease in adult asthma: A systematic literature review
Omar S. Usmani et al.
RESPIRATORY MEDICINE (2016)
The minimal important difference for the St George's Respiratory Questionnaire in patients with severe COPD
Jorrit B. A. Welling et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study
David B. Price et al.
LANCET RESPIRATORY MEDICINE (2015)
Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study
P. E. Silkoff et al.
RESPIRATORY RESEARCH (2015)
High blood eosinophil count is associated with more frequent asthma attacks in asthma patients
Trung N. Tran et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2014)
An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease
Sally J. Singh et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease
Anne E. Holland et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Minimal Clinically Important Difference Defining What Really Matters to Patients
Anna E. McGlothlin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Monitoring childhood asthma: Web-based diaries and the asthma control test
Sandra Voorend-van Bergen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2014)
Loss of Salmeterol Bronchoprotection against Exercise in Relation to ADRB2 Arg16Gly Polymorphism and Exhaled Nitric Oxide
Matteo Bonini et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
A trial of beclomethasone/formoterol in COPD using EXACT-PRO to measure exacerbations
Dave Singh et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Why inflammatory phenotyping is necessary for successful drug evaluation in asthma and COPD
Peter G. Gibson
EUROPEAN RESPIRATORY JOURNAL (2013)
Sample sizes for clinical trials using sputum eosinophils as a primary outcome
Angira Dasgupta et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects
Annette T. Hastie et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Sex differences in asthma symptom profiles and control in the American Lung Association Asthma Clinical Research Centers
Jennifer W. McCollister et al.
RESPIRATORY MEDICINE (2013)
Comparison between an online self-administered and an interviewer-administered version of the Asthma Control Questionnaire: a cross-sectional validation study
Persijn J. Honkoop et al.
PRIMARY CARE RESPIRATORY JOURNAL (2013)
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial
Alberto Papi et al.
LANCET RESPIRATORY MEDICINE (2013)
Asthma outcomes: Symptoms
Jerry A. Krishnan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Asthma Symptom Utility Index: Reliability, validity, responsiveness, and the minimal important difference in adult asthmatic patients
Christian Bime et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Asthma outcomes: Biomarkers
Stanley J. Szefler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Theo Vos et al.
LANCET (2012)
Clinimetrics corner: a closer look at the minimal clinically important difference (MCID)
Alexis Wright et al.
JOURNAL OF MANUAL & MANIPULATIVE THERAPY (2012)
An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications
Raed A. Dweik et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
The increase in exhaled NO following allergen challenge is not associated with airway acidification
Giovanni Rolla et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The small airways and distal lung compartment in asthma and COPD: a time for reappraisal
M. Contoli et al.
ALLERGY (2010)
Asthma Control Questionnaire in children: validation, measurement properties, interpretation
E. F. Juniper et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Minimal Clinically Important Difference
Robert J. Gatchel et al.
SPINE (2010)
The role of small airways in monitoring the response to asthma treatment: what is beyond FEV1?
N. Scichilone et al.
ALLERGY (2009)
Relationship between pretreatment specific IgE and the response to omalizumab therapy
U. Wahn et al.
ALLERGY (2009)
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations Standardising Endpoints for Clinical Asthma Trials and Clinical Practice
Helen K. Reddel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Perception of airflow obstruction in patients hospitalized for acute asthma
Steven Q. Davis et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2009)
Exhaled Nitric Oxide and Breath Condensate pH in Asthmatic Reactions Induced by Isocyanates
Silvia Ferrazzoni et al.
CHEST (2009)
What defines airflow obstruction in asthma?
I. Cerveri et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
The minimally important difference of the Asthma Control Test
Michael Schatz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Using the entire cohort in the receiver operating characteristic analysis maximizes precision of the minimal important difference
Dan Turner et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Disability in valued life activities among individuals with systemic lupus erythematosus
Patricia Katz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
A. Michils et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation
Ronald L. Sorkness et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
Dennis Revicki et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
The minimal detectable change of the simplified stroke rehabilitation assessment of movement measure
Wen-Shian Lu et al.
JOURNAL OF REHABILITATION MEDICINE (2008)
Identifying Myelopathy Caused by Thoracic Syringomyelia: A Case Report
Beverly Rene Hudson et al.
JOURNAL OF MANUAL & MANIPULATIVE THERAPY (2008)
Development and cross-sectional validation of the Childhood Asthma Control Test
Andrew H. Liu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Recommendations on the use of exercise testing in clinical practice
P. Palange et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Understanding the minimum clinically important difference: a review of concepts and methods
Anne G. Copay et al.
SPINE JOURNAL (2007)
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study
Klaus F. Rabe et al.
LANCET (2006)
Daily ambulatory exhaled nitric oxide measurements in asthma
MW Pijnenburg et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2006)
Interpretative strategies for lung function tests
R Pellegrino et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years
F Buchvald et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Measurement properties and interpretation of three shortened versions of the asthma control questionnaire
EF Juniper et al.
RESPIRATORY MEDICINE (2005)
Estimating clinically significant differences in quality of life outcomes
KW Wyrwich et al.
QUALITY OF LIFE RESEARCH (2005)
Development of the asthma control test: A survey for assessing asthma control
RA Nathan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
An integrated method to determine meaningful changes in health-related quality of life
RD Crosby et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
M Masoli et al.
ALLERGY (2004)
Interpretation of changes in health-related quality of life - The remarkable universality of half a standard deviation
GR Norman et al.
MEDICAL CARE (2003)
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial
RA Pauwels et al.
LANCET (2003)
Short-term variability of exhaled nitric oxide in young male patients with mild asthma and in healthy subjects
H Ekroos et al.
RESPIRATORY MEDICINE (2002)
Changes of exhaled nitric oxide during steroid treatment of childhood asthma
J Beck-Ripp et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control
SL Jones et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain
S Solway et al.
CHEST (2001)
Validation of a pediatric asthma caregiver diary
NC Santanello et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Identifying meaningful intra-individual change standards for health-related quality of life measures
KW Wyrwich et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2000)
Share Paper
